Three types of adherence to HIV antiretroviral therapy and their association with AIDS diagnosis, medication side-effects, beliefs about antiretroviral therapy, and beliefs about HIV disease

International Journal of STD and AIDS

Volumn 18, Issue 6, 2007, Pages 369-373

  Schönnesson, Lena Nilsson ^a,c   Williams, Mark L ^b   Ross, Michael W ^b   Diamond, Pamela M ^b   Keel, Blair ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

Adherence; AIDS; Health beliefs; HIV infection; Medication side effects

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIET; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; FEMALE; GROUPS BY AGE; HEALTH BELIEF; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF CONCEPT; SPOUSE; UNSPECIFIED SIDE EFFECT; ATTITUDE TO HEALTH; MIDDLE AGED; PSYCHOLOGICAL ASPECT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATTITUDE TO HEALTH; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; QUESTIONNAIRES;

EID: 34748890027     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646207781024757     Document Type: Article

References (37)

1. Poppa A, Davidson D, Deutsch J, et al. British HIV Association (BHIVA)/British Association for asexual health and HIV (N′BASHH) guidelines on provision of adherence support to individuals receiving antiretroviral therapy (2003). HIV Med 2004;5(Suppl 2):46-60
2. Sherr L, Bangsberg DR, Hecht FM, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000;14:357-66
3. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30
4. Murphy DA, Marelich D, Hoffman D, Steers WN. Predictors of antiretroviral adherence. AIDS Care 2004;16:471-84
5. Simoni JM, Frick PA, Lockhart D, Liebovitz D. Mediators of social support and antiretroviral adherence among an indigent population in New York City. AIDS Patiet Care STDs 2002;16:431-9
6. Kleeberger CA, Phair JP, Strathdee SA, et al. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2001;26:82-92
7. Glanz K, Lewis F, Rimer B. Health Behavior and Health Education. San Francisco, CA: Jossey-Bass, 1997
8. Leventhal H, Diefenback M, Leventhal EA. Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Special issue: Cognitive perspectives in health psychology. Cognitive Ther Res 1992;16:143-63
9. Horne R. Representations of medication and treatment: advances in theory and measurement. In: Petrie KJ, Weinman J, eds. Perceptions of Health and Illness: Current Research and Applications. Singapore: Harwood Academic, 1997;155-88
10. Reynolds NR. The problem of antiretroviral adherence: a self-regulatory model for intervention. AIDS Care 2003;15:117-24
11. Horne R. Patients' belief about treatment: the hidden determinant of treatment outcome. J Psychosom Resh 1999;47:491-5
12. Nicolet CM, Theunissen NCM, De Ridder DTD, Bensing JM, Rutten GEHM. Manipulation of patient-provider interaction: discussing illness representations or action plans concerning adherence. Patient Educat Counsel 2003;51:247-58
13. Horne R, Pearson S, Leake H. Patients' belief about HAART influence adherence to antiretroviral therapy. Abstract 588. Presented at the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco 1999
14. Wenger N, et al. Patient Characteristics and Attitudes associated with antiretroviral (ART) adherence. Abstract No.98 Presented at the VI Conference on Retrovirus and Opportunistic Infections, Washington, DC, 1999
15. Muma RD, Ross MW, Parcel GS, Pollard RB. Zidovudine adherence among individuals with HIV infection. AIDS Care 1995;7:439-47
16. Samet JH, Libman H, Steger J, et al. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic. Am J Med 1992;92:495-502
17. Chesney MA, Ickovic JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials. AIDS Care 2000;12:255-66
18. Tuldra A, Fumaz CR, Ferrer MJ, et al. Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral medication. J Acquir Immune Defic Syndr 2000;25:221-8
19. Gifford A, Borman J, Shivley M, et al. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr 2000;23:386-95
20. Eldred LJ, Wu AW, Chaisson RE, et al. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr 1998;18:117-25
21. Horne R, Buick D, Fisher M, Leake H. Perceptions of HIV and HAART as barriers to adherence to HAART. Abstract 35.1 Presented at the Fifth International Conference AIDS Impact - Biopsychosocial Aspects of HIV Infection, Brighton, 2001
22. Gao X, Nau DP, Rosenbluth SA, et al. The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care 2000;12:387-98
23. Geletko SM, Ballard CR, Mathews WC. Health beliefs and discontinuation of zidovudine therapy. Am J Health-System Pharmacy 1995;52:505-7
24. Ickovics JR, Meade CS. Adherence to HAART among patients with HIV: breakthroughs and barriers. AIDS Care 2002;14:309-18
25. Nieuwkerk PT, Sprangers MAG, Burger DM, et al. Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study. Arch Intern Med 2001;14:357-66
26. Stone VE, Hogam JW, Schuman P, et al. Antiretroviral regimen complexity, self-reported adherence, and HIV-patients' understanding of their regimens: survey of women in the HER study. J Acquir Immune Defic Syndr 2001;28:124-31
27. Murphy DA, Greewell L, Hoffman D. Factors associated with antiretroviral adherence among HIV-infected women with children. Women Health 2002;36:97-111
28. Nilsson Schönnesson L, Ross MW, Williams ML. The HIV medication self-reported non-adherence reasons (SNAR) index and its underlying psychological dimensions. AIDS & Behavior 2004;8:293-301
29. Nilsson Schönnesson L, Williams ML, Ross MW, Diamond PM, Keel B. Factors associated with suboptimal antiretroviral therapy adherence to dose, schedule, and dietary instructions. AIDS & Behavior 2007;11:175-83
30. Bartlett JA. Addressing the challenges of adherence. J Acquir Immune Defic Syndr 2002;29(Suppl 1):S2-10
31. Heath KV, Singer J, O'Shaughnessy MV, Montaner JSG, Hogg RS. Intentional nonadherence due to adverse symptoms associated with antiretroviral medication. J Acquir Immune Defic Syndr 2002;31:211-17
32. Ammassari A, Murri R, Pezzotti P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral medication in persons with HIV infection. J Acquir Immune Defic Syndr 2001;28:445-9
33. Duran S, Spire B, Raffi F, et al. Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clin Trials 2001;2:38-45
34. Cederfjäll C, Aspects of care among HIV-infected patients. Needs, adherence to treatment and health related quality of life. Doctoral Dissertation. Stockholm: Karolinska Institute, 2002
35. Jensen-Fangel S, Pedersen L, Pedersen C, et al. The effect of race/ethnicity on the outcome of highly active antiretroviral medication for human immunodeficiency virus type 1-infected patients. Clin Infect Dis 2002;35:1541-8
36. Walsh JC, Horne R, Dalton M, et al. Reasons for non-adherence to antiretroviral medication: patients' perspectives provide evidence of multiple causes. AIDS Care 2001;13:709-20
37. Molassiotis A, Nahas-Lopez V, Chung RWY, et al. Factors associated with adherence to antiretroviral medication in HIV-infected patients. Int J STD AIDS 2002;13:301-10